Advertisement
Advertisement
U.S. markets open in 2 hours 15 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Disc Medicine, Inc. (IRON)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
48.43+0.79 (+1.66%)
At close: 04:00PM EDT
48.43 0.00 (0.00%)
After hours: 04:01PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Williams %R

Williams %R

Performance Outlook
Previous Close47.64
Open47.20
Bid0.00 x 800
Ask0.00 x 1000
Day's Range47.20 - 49.50
52 Week Range15.00 - 63.00
Volume165,127
Avg. Volume210,857
Market Cap1.108B
Beta (5Y Monthly)N/A
PE Ratio (TTM)4.95
EPS (TTM)9.78
Earnings DateNov 08, 2023 - Nov 13, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est67.11
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for IRON

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Disc Medicine, Inc.
    Daily – Vickers Top Buyers & Sellers for 09/19/2023The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    8 days agoArgus Research
View more
  • GlobeNewswire

    Disc Medicine Receives FDA Fast Track Designation for MWTX-003 for the Treatment of Polycythemia Vera

    WATERTOWN, Mass., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced that the United States Food and Drug Administration (FDA) has granted Fast Track Designation to MWTX-003 for the treatment of patients with polycythemia vera (PV). “We are delighted to have received Fast Track desi

  • Simply Wall St.

    With 52% ownership, Disc Medicine Opco Inc (NASDAQ:IRON) boasts of strong institutional backing

    Key Insights Institutions' substantial holdings in Disc Medicine Opco implies that they have significant influence over...

  • GlobeNewswire

    Disc Medicine to Participate in Upcoming Investor Conferences

    WATERTOWN, Mass., Aug. 30, 2023 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, announced today that company management will participate in fireside chats at four upcoming investor conferences: The 2023 Wells Fargo Healthcare Conference on Friday, September 8th at 8:45 am ET.The Morgan Stanley 21st Annual Glob

Advertisement
Advertisement